RELEASE: CMS Announces Next 15 Drugs Selected for Medicare Negotiation, Building On Historic Efforts To Lower Drug Prices
Patients For Affordable Drugs Celebrates Another Critical Step Forward in the Fight Against Skyrocketing Prescription Costs
STATEMENT: Patients For Affordable Drugs Responds To Teva Pharmaceuticals’ Lawsuit To Stop Medicare Drug Price Negotiations
The Brief Counters Insulin Manufacturer’s Legal Arguments, Recounts The History Of Big Pharma’s Opposition To Medicare Negotiation, And Demonstrates The Program’s Positive Impact On Millions Of Patients
ICYMI: Patients On Medicare Celebrate $2,000 Cap On Out-Of-Pocket Costs
Millions Of Patients Anticipate Substantial Savings As New Limit On Annual Out-of-Pocket Costs Goes Into Effect January 1st
STATEMENT: Patients For Affordable Drugs Files Second Patient-Focused Amicus Brief Defending Medicare Negotiation Against Big Drug Company’s Legal Assault
The Brief Counters Insulin Manufacturer’s Legal Arguments, Recounts The History Of Big Pharma’s Opposition To Medicare Negotiation, And Demonstrates The Program’s Positive Impact On Millions Of Patients
STATEMENT: Patients For Affordable Drugs Responds to Consolidated Oral Arguments Made In First Appeal Heard Against Medicare Negotiation
STATEMENT: Patients For Affordable Drugs Responds to Consolidated Oral Arguments Made In First Appeal Heard Against Medicare Negotiation
ICYMI: Patients Score Eighth Legal Victory As Court Rejects Novartis Challenge to Medicare Negotiation Program
ICYMI: Patients Score Eighth Legal Victory As Court Rejects Novartis Challenge to Medicare Negotiation Program
RELEASE: Patients For Affordable Drugs Exposes Cancer Medication Price Hikes Disproportionately Harming Black And Latino Communities
NBC News Reports Soaring Medication Costs Force Patients Of Color To Make Impossible Choices
STATEMENT: In A Procedural Ruling, Appeals Court Allows Pharma Trade Association To Proceed With Suit Opposing Medicare Negotiation In Fifth Circuit
District Court Will Now Hear A Suit On The Merits–Like The Industry Has Lost In Every Other Jurisdiction
